Aemetis (NASDAQ:AMTX) Price Target Raised to $21.00
by Jessica Moore · The Cerbat GemAemetis (NASDAQ:AMTX – Free Report) had its price target lifted by Ascendiant Capital Markets from $20.00 to $21.00 in a report published on Wednesday,Benzinga reports. Ascendiant Capital Markets currently has a buy rating on the specialty chemicals company’s stock.
Several other research firms also recently weighed in on AMTX. Weiss Ratings reiterated a “sell (e+)” rating on shares of Aemetis in a research report on Wednesday, January 21st. Loop Capital set a $1.75 target price on Aemetis in a research report on Thursday, March 12th. Finally, Wall Street Zen upgraded Aemetis from a “sell” rating to a “hold” rating in a research report on Sunday, March 22nd. Two research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $8.58.
Check Out Our Latest Report on Aemetis
Aemetis Stock Down 5.4%
Shares of AMTX opened at $2.27 on Wednesday. The company has a market cap of $154.69 million, a PE ratio of -1.71 and a beta of 1.48. The business has a fifty day moving average of $2.08 and a 200 day moving average of $1.97. Aemetis has a 52-week low of $1.22 and a 52-week high of $3.66.
Aemetis (NASDAQ:AMTX – Get Free Report) last issued its quarterly earnings results on Thursday, March 12th. The specialty chemicals company reported ($0.24) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.28) by $0.04. The company had revenue of $43.31 million during the quarter, compared to the consensus estimate of $72.07 million. As a group, research analysts anticipate that Aemetis will post -2.07 earnings per share for the current fiscal year.
Institutional Investors Weigh In On Aemetis
Institutional investors and hedge funds have recently modified their holdings of the company. Vanguard Group Inc. boosted its position in Aemetis by 15.3% in the 3rd quarter. Vanguard Group Inc. now owns 2,479,163 shares of the specialty chemicals company’s stock worth $5,578,000 after purchasing an additional 329,760 shares in the last quarter. Jane Street Group LLC acquired a new position in shares of Aemetis during the 2nd quarter worth approximately $634,000. Squarepoint Ops LLC raised its stake in shares of Aemetis by 462.6% during the 4th quarter. Squarepoint Ops LLC now owns 177,215 shares of the specialty chemicals company’s stock worth $246,000 after buying an additional 145,716 shares during the period. Qube Research & Technologies Ltd acquired a new position in shares of Aemetis during the 2nd quarter worth approximately $246,000. Finally, Russell Investments Group Ltd. raised its stake in shares of Aemetis by 412.9% during the 2nd quarter. Russell Investments Group Ltd. now owns 80,754 shares of the specialty chemicals company’s stock worth $200,000 after buying an additional 65,010 shares during the period. Institutional investors and hedge funds own 27.02% of the company’s stock.
About Aemetis
Aemetis, Inc, headquartered in Cupertino, California, is a renewable fuels and renewable natural gas producer dedicated to decarbonizing the transportation sector. The company operates two primary business segments: Aemetis Advanced Fuels, which manufactures ethanol, biodiesel and sustainable aviation fuel using patented carbon capture and separation technology; and Aemetis RNG, which develops dairy-based renewable natural gas projects in California for pipeline injection and transportation use.
Since its incorporation in 2006, Aemetis has expanded its production footprint through organic growth and strategic acquisitions.